ANDA 90387, held by Hikma. Testosterone Cypionate.
As of Nov 16, 2026, ANDA 90387 (Testosterone Cypionate), held by Hikma, was first approved by FDA on Jul 15, 2010, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 2010 | Original application | Approved | None posted |
| Testosterone Cypionate100MG/ML · injectable;injection | Testosterone Cypionate | Rx |
| Testosterone Cypionate200MG/ML · injectable;injection | Testosterone Cypionate | Rx |
| Jul 14, 2025 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jun 19, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jul 15, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters